approach to pulmonary problems of immunosuppressed patients
DESCRIPTION
Approach to Pulmonary Problems of Immunosuppressed Patients. Dr.Özlem Özdemir Kumbasar. Pulmonary complications are frequent and life-threatining problems in immunocompromised patients. Early diagnosis for optimal treatment is very important. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/1.jpg)
1
Approach to Pulmonary Problems of Immunosuppressed Patients
Dr.Özlem Özdemir Kumbasar
![Page 2: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/2.jpg)
2
Pulmonary complications are frequent and life-threatining problems in immunocompromised patients.
Early diagnosis for optimal treatment is very important.
Empirical therapy should be started as soon as possible for most of the patients.
![Page 3: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/3.jpg)
3
The number of immunosuppressed patients has increased recently: Neutropenia following cancer chemotherapy Hematological malignancy Solid organ transplantation Hematopoietic stem cell transplantation Immunosuppressive treatments for auto-
immune diseases HIV infection …………
![Page 4: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/4.jpg)
4
Rapid diagnosis is necessary because of high mortality.
To obtain an etiological diagnosis is usually difficult and sometimes requires invasive diagnostic methods.
![Page 5: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/5.jpg)
5
To obtain an etiological diagnosis is difficult. Because: Clinical findings may be silent Clinical picture is nonspecific Infectious and non-infectious diseases
can be seen together More than one infectious agent may be
responsible for the pulmonary problem
![Page 6: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/6.jpg)
6
Sometimes invasive diagnostic methods are necessary. But, usually these procedures are difficult for these patients: General condition of the patient? Respiratory failure? Thrombocytopenia?
![Page 7: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/7.jpg)
7
Approach to Pulmonary Complications in an Immunosupressed Patient Clinical evaluation Radiologial findings
Empirical treatment Diagnostic tests
![Page 8: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/8.jpg)
8
Clinical Evaluation Type of imunosuppression
Neutropenia Humoral immunodeficiency Cellular immunodeficiency
![Page 9: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/9.jpg)
9
Neutropenia Gram-negative rods S.aureus Coagulase-negative staphylococci Viridans streptococci Aspergillus
![Page 10: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/10.jpg)
10
Neutropenia Long lasting profound neutropenia:
Fungi Multiresistent gram negative rods (P.aeruginosa,
S.maltophilia) and other bacteria P.jiroveci Viruses ……………
Noninfectious diseases Alveolar bleeding COP Lesions due to chemo- or radiotherapy Malign infiltration ……………
![Page 11: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/11.jpg)
11
Humoral immunosuppresion Pneumococcus H.influenzae
![Page 12: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/12.jpg)
12
Cellular immunosuppression M.tuberculosis P.jiroveci Legionella Nocardia Nontuberculous mycobacteria Fungi Viruses
![Page 13: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/13.jpg)
13
Clinical evaluation Medical history
Type, intensity and duration of immunosuppression
Previous treatments Prophylaxis CAP? HAP? Condition of the hospital
![Page 14: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/14.jpg)
14
Clinical evaluation Timing of the complication
HSCT SOT
![Page 15: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/15.jpg)
15
Timing HSCT
Preengraftment phase (0-30days) Bacteria, Candida, Aspergillus DAH, IPS, engraftment syndrome
Early postengraftment phase (30-100days) CMV, PCP, Aspergillus IPS
Late posttransplant phase (>100days) CMV, VZV, community acquired viruses,
pneumococcus, H.influenzae, tuberculosis BOOP PTLD BO
![Page 16: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/16.jpg)
16
Timing SOT
0-1 month: HAP Fungi
1-6 months: Aspergillus PCP CMV, other viruses Nocardia
>6 months: CAP Tuberculosis
![Page 17: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/17.jpg)
17
Clinical evaluation Clinical behavior of the complication
Acute Bacteria Viruses PCP (nonHIV patients) Pulmonary edema, DAH, PTE….
Subacute/chronic Aspergillus CMV Nocardia Tuberculosis
![Page 18: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/18.jpg)
18
Symptoms Symptoms are usually nonspecific
Cough Fever Dyspnea Skin lesions-bacteria, fungi
Nodules-Aspergillus, Nocardia Invasive sinusitis-mucor, Aspergillus, Fusarium Corioretinitis-CMV Brain abscess-Nocardia, Aspergillus,
Pseudomonas, Toxoplasma
![Page 19: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/19.jpg)
19
Radiological findings To evaluate radiological clues is
vey important for planning rapid and optimal empirical therapy
The main radiological patterns: Focal infiltrate-consolidation Nodular infiltrates Diffuse interstitial infiltrates
![Page 20: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/20.jpg)
20
Additional radiological findings Cavitation Pleural effusion Atelectasis Lymphadenopathy Pneumothorax
![Page 21: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/21.jpg)
21
Acute/focal infiltrates Bacteria Aspergillus Legionella
Subacute-chronic/focal infiltrates Aspergillus Nocardia M.tuberculosis, MAI
![Page 22: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/22.jpg)
22
Acute/nodular(+cavity) infiltrates Bacterial lung abscess Legionella
Subacute-chronic/nodular (+cavity) Tuberculosis Nocardia Aspergillus Cryptococcus
![Page 23: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/23.jpg)
23
Acute/diffuse interstitial infiltrates CMV P.jiroveci
Subacute-chronic/diffuse intertitial CMV P.jiroveci RSV Miliary tuberculosis
![Page 24: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/24.jpg)
24
![Page 25: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/25.jpg)
25
![Page 26: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/26.jpg)
26
![Page 27: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/27.jpg)
27
![Page 28: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/28.jpg)
28
![Page 29: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/29.jpg)
29
Noninfectious disorders Diffuse
Pulmonary edema BOOP-COP NSIP LIP Drug induced pneumonitis Lymphangitic metastasis DAH IPS Radiation toxicity PAP
![Page 30: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/30.jpg)
30
Noninfectious disorders Nodular + cavity
Malignancy Septic embolism Kaposi sarcoma Posttransplant lymphoprolipherative
disorder
![Page 31: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/31.jpg)
31
Noninfectious disorders Focal
BOOP-COP Radiation toxicity Pulmonary embolism and infarctus Phantom tumor Primary/metastatic tumor Atelectasis Kaposi
![Page 32: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/32.jpg)
32
![Page 33: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/33.jpg)
33
Computed tomography detects pulmonary iniltrates earlier than chest x-ray.
CT gives valuable information about characteristics of the pulmonary infiltrate. The diagnosis of pulmonary aspergillosis,
PCP, CMV pneumonia could be suspected from the typical CT findings.
![Page 34: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/34.jpg)
34
CT findings of invasive pulmonary aspergillosis Single or multiple nodules Mass like appearence Consolidation-especially pleural based,
wedge shaped Halo sign Cavitation Air-crescent sign
![Page 35: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/35.jpg)
35
![Page 36: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/36.jpg)
36
![Page 37: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/37.jpg)
37
![Page 38: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/38.jpg)
38
![Page 39: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/39.jpg)
39
Similar BT findings may be seen in other invasive fungal infections, nocardiosis.
![Page 40: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/40.jpg)
40
Halo sign- IPA->%60 (early finding) Pulmonary zygomycosis-%25
![Page 41: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/41.jpg)
41
Reverse halo sign Central ground-glass opacity,
surrounding consolidation Reverse halo sign may be seen in
COP
![Page 42: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/42.jpg)
42
![Page 43: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/43.jpg)
43
189 patients with fungal pneumonia Reverse halo sign in 8 patients (7-
zygomycosis; 1 aspergillosis) Reverse halo sign was detected in
19% of patients with zygomycosis and <1% of aspergillosis.
![Page 44: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/44.jpg)
44
PCP-CT findings: Ground glass opacities Interlobular septal thickening Cystic lesions
![Page 45: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/45.jpg)
45
PCP
![Page 46: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/46.jpg)
46
OP
![Page 47: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/47.jpg)
47
![Page 48: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/48.jpg)
48
![Page 49: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/49.jpg)
49
![Page 50: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/50.jpg)
50
![Page 51: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/51.jpg)
51
![Page 52: Approach to Pulmonary Problems of Immunosuppressed Patients](https://reader036.vdocument.in/reader036/viewer/2022081520/56815e08550346895dcc5db9/html5/thumbnails/52.jpg)
52